Business Insider2d
Biomea Fusion’s icovamenib shows efficacy in Type 2 diabetes trial
Biomea Fusion (BMEA) announced its presentations at the 1st Annual Asian Conference on Innovative Therapies for Diabetes Management in Singapore, 18-20 November. Biomea will showcase three oral ...
Biomea Fusion, Inc. (NASDAQ:BMEA) Shares Sold by GSA Capital Partners LLP
GSA Capital Partners LLP lowered its stake in shares of Biomea Fusion, Inc. (NASDAQ:BMEA – Free Report) by 36.8% during the third quarter, according to the company in its most recent disclosure with ...
We're A Little Worried About Biomea Fusion's (NASDAQ:BMEA) Cash Burn Rate
Having said that, unprofitable companies are risky because they could potentially burn through all their cash and become distressed. So, the natural question for Biomea Fusion (NASDAQ:BMEA) ...
ETF Daily News14d
Biomea Fusion FY2024 EPS Estimate Increased by HC Wainwright
Biomea Fusion, Inc. (NASDAQ:BMEA – Free Report) – Investment analysts at HC Wainwright lifted their FY2024 earnings estimates for shares of Biomea Fusion in a research note issued on Thursday ...
Investing15d
Biomea Fusion's SWOT analysis: clinical hold clouds diabetes drug stock outlook
Biomea Fusion Inc. (NASDAQ:BMEA), a biotechnology company focused on developing innovative treatments for diabetes and obesity, finds itself at a critical juncture as it navigates regulatory ...
Investing15d
Biomea Fusion's SWOT analysis: clinical hold clouds diabetes drug stock outlook
Biomea Fusion Inc. (NASDAQ:BMEA), a biotechnology company focused on developing innovative treatments for diabetes and obesity, finds itself at a critical juncture as it navigates regulatory ...
bovnews18d
Biomea Fusion Inc (BMEA) Stock: Greater Than Its Current Valuation?
On Thursday, Biomea Fusion Inc (BMEA) stock saw a decline, ending the day at $9.37 which represents a decrease of $-0.97 or -9.38% from the prior close of $10.34. The stock opened at $10.46 and ...
Stockhouse18d
Biomea Fusion, Inc. Reports Inducement Grant under Nasdaq Listing Rule 5635(c)(4)
REDWOOD CITY, Calif., Nov. 01, 2024 (GLOBE NEWSWIRE) -- Biomea Fusion, Inc. (Nasdaq: BMEA) (“Biomea” or the “Company”), a clinical stage biopharmaceutical ...
Mena FN18d
Biomea Fusion, Inc. Reports Inducement Grant Under Nasdaq Listing Rule 5635(C)(4)
(MENAFN- GlobeNewsWire - Nasdaq) REDWOOD CITY, Calif., Nov. 01, 2024 (GLOBE NEWSWIRE) -- Biomea Fusion, Inc. (Nasdaq: BMEA) (“Biomea” or the“Company”), a ...
Yahoo Finance18d
Biomea Fusion, Inc. Reports Inducement Grant under Nasdaq Listing Rule 5635(c)(4)
Biomea Fusion, Inc. REDWOOD CITY, Calif., Nov. 01, 2024 (GLOBE NEWSWIRE) -- Biomea Fusion, Inc. (Nasdaq: BMEA) (“Biomea” or the “Company”), a clinical stage biopharmaceutical company ...
Yahoo Finance18d
Biomea Fusion, Inc. Reports Inducement Grant under Nasdaq Listing Rule 5635(c)(4)
REDWOOD CITY, Calif., Nov. 01, 2024 (GLOBE NEWSWIRE) -- Biomea Fusion, Inc. (Nasdaq: BMEA) (“Biomea” or the “Company”), a clinical stage biopharmaceutical company focused on the discovery and ...